Your browser doesn't support javascript.
loading
RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.
Baranello, Laura; Wojtowicz, Damian; Cui, Kairong; Devaiah, Ballachanda N; Chung, Hye-Jung; Chan-Salis, Ka Yim; Guha, Rajarshi; Wilson, Kelli; Zhang, Xiaohu; Zhang, Hongliang; Piotrowski, Jason; Thomas, Craig J; Singer, Dinah S; Pugh, B Franklin; Pommier, Yves; Przytycka, Teresa M; Kouzine, Fedor; Lewis, Brian A; Zhao, Keji; Levens, David.
Afiliação
  • Baranello L; Laboratory of Pathology, NCI/NIH, Bethesda, MD 20892, USA.
  • Wojtowicz D; Computational Biology Branch, NCBI/NIH, Bethesda, MD 20892, USA.
  • Cui K; Systems Biology Center, NHLBI/NIH, Bethesda, MD 20892, USA.
  • Devaiah BN; Experimental Immunology Branch, NCI/NIH, Bethesda, MD 20892, USA.
  • Chung HJ; Laboratory of Pathology, NCI/NIH, Bethesda, MD 20892, USA.
  • Chan-Salis KY; Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802, USA.
  • Guha R; Division of Preclinical Innovation, NCATS/NIH, Rockville, MD 20850, USA.
  • Wilson K; Division of Preclinical Innovation, NCATS/NIH, Rockville, MD 20850, USA.
  • Zhang X; Division of Preclinical Innovation, NCATS/NIH, Rockville, MD 20850, USA.
  • Zhang H; Development Therapeutics Branch and Laboratory of Molecular Pharmacology, NCI/NIH, Bethesda, MD 20892, USA.
  • Piotrowski J; Lymphoid Malignancies Branch, NCI/NIH, Bethesda, MD 20892, USA.
  • Thomas CJ; Division of Preclinical Innovation, NCATS/NIH, Rockville, MD 20850, USA.
  • Singer DS; Experimental Immunology Branch, NCI/NIH, Bethesda, MD 20892, USA.
  • Pugh BF; Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802, USA.
  • Pommier Y; Development Therapeutics Branch and Laboratory of Molecular Pharmacology, NCI/NIH, Bethesda, MD 20892, USA.
  • Przytycka TM; Computational Biology Branch, NCBI/NIH, Bethesda, MD 20892, USA.
  • Kouzine F; Laboratory of Pathology, NCI/NIH, Bethesda, MD 20892, USA.
  • Lewis BA; Lymphoid Malignancies Branch, NCI/NIH, Bethesda, MD 20892, USA.
  • Zhao K; Systems Biology Center, NHLBI/NIH, Bethesda, MD 20892, USA. Electronic address: zhaok@nhlbi.nih.gov.
  • Levens D; Laboratory of Pathology, NCI/NIH, Bethesda, MD 20892, USA. Electronic address: levens@helix.nih.gov.
Cell ; 165(2): 357-71, 2016 Apr 07.
Article em En | MEDLINE | ID: mdl-27058666
We report a mechanism through which the transcription machinery directly controls topoisomerase 1 (TOP1) activity to adjust DNA topology throughout the transcription cycle. By comparing TOP1 occupancy using chromatin immunoprecipitation sequencing (ChIP-seq) versus TOP1 activity using topoisomerase 1 sequencing (TOP1-seq), a method reported here to map catalytically engaged TOP1, TOP1 bound at promoters was discovered to become fully active only after pause-release. This transition coupled the phosphorylation of the carboxyl-terminal-domain (CTD) of RNA polymerase II (RNAPII) with stimulation of TOP1 above its basal rate, enhancing its processivity. TOP1 stimulation is strongly dependent on the kinase activity of BRD4, a protein that phosphorylates Ser2-CTD and regulates RNAPII pause-release. Thus the coordinated action of BRD4 and TOP1 overcame the torsional stress opposing transcription as RNAPII commenced elongation but preserved negative supercoiling that assists promoter melting at start sites. This nexus between transcription and DNA topology promises to elicit new strategies to intercept pathological gene expression.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcrição Gênica / RNA Polimerase II / DNA / DNA Topoisomerases Tipo I Limite: Humans Idioma: En Revista: Cell Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transcrição Gênica / RNA Polimerase II / DNA / DNA Topoisomerases Tipo I Limite: Humans Idioma: En Revista: Cell Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos